期刊
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
卷 60, 期 38, 页码 20888-20896出版社
WILEY-V C H VERLAG GMBH
DOI: 10.1002/anie.202106730
关键词
activatable probe; adoptive immunotherapy; cell viability imaging; natural killer cell; NIR-II fluorescence imaging
资金
- Natural Science Foundation of China [61727823, 21874024, 22027805]
- National Key R&D Program of China [2020YFA0210800]
- Natural Science Foundation of Fujian Province of China [2020J011152, 2020J02010]
- Project of Fuzhou Science and Technology Department [2020-WS-56]
The study introduces a novel ratiometric NIR-II fluorescence imaging strategy to track and visualize NK cell viability in vivo, demonstrating that co-treatment with IL-2, IL-15, and IL-21 can enhance NK cell viability and improve immunotherapy for hepatocellular carcinoma. This approach allows for longitudinal and quantitative monitoring of NK cell viability in NK cell-based immunotherapy.
The therapeutic efficacy of natural killer (NK) cells-based immunotherapy is greatly related with the survival of transplanted NK cells. However, no effective strategy was reported to monitor NK cell viability in adoptive immunotherapy in vivo. Herein, we develop a ratiometric NIR-II fluorescence imaging strategy to quantitively track and visualize the adoptive NK cell viability in vivo in real-time. The nanoprobe consists of lanthanide-based down-conversion nanoparticles (DCNP) coated with IR786s, a reactive oxygen species (ROS) sensitive to NIR dye, which was directly labeled with NK cells. Upon cell death, the excessive ROS generation occurred within NK cells, along with IR786s degradation, turning on NIR-II fluorescent signal at 1550 nm of DCNP under 808-nm excitation, while the fluorescent signal at 1550 nm of DCNP under 980-nm excitation was stable. Such an intracellular ROS-induced ratiometric NIR-II fluorescent signal was validated to correlate well with NK cell viability in vivo. Using this nanoreporter, we further demonstrated that co-treatment with IL-2, IL-15, and IL-21 could improve NK cell viability in vivo, achieving enhanced immunotherapy for orthotopic hepatocellular carcinoma. Overall, this strategy allows for longitudinal and quantitative tracking of NK cell viability in NK cell-based immunotherapy.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据